Liu Yang, Ma Xiwen, Zhang Donghui, Geng Lijiang, Wang Xiaojing, Zheng Wei, Chen Ming-Hui
Department of Statistics, University of Connecticut, Storrs, Connecticut, USA.
Biostatistics Department, Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
J Biopharm Stat. 2019;29(6):1082-1102. doi: 10.1080/10543406.2019.1584204. Epub 2019 Mar 12.
Subgroup analysis, as the key component of personalized medicine development, has attracted a lot of interest in recent years. While a number of exploratory subgroup searching approaches have been proposed, informative evaluation criteria and scenario-based systematic comparison of these methods are still underdeveloped topics. In this article, we propose two evaluation criteria in connection with traditional type I error and power concepts, and another criterion to directly assess recovery performance of the underlying treatment effect structure. Extensive simulation studies are carried out to investigate empirical performance of a variety of tree-based exploratory subgroup methods under the proposed criteria. A real data application is also included to illustrate the necessity and importance of method evaluation.
亚组分析作为个性化医疗发展的关键组成部分,近年来引起了广泛关注。虽然已经提出了许多探索性亚组搜索方法,但这些方法的信息性评估标准以及基于场景的系统比较仍未得到充分发展。在本文中,我们提出了两个与传统I型错误和检验功效概念相关的评估标准,以及另一个直接评估潜在治疗效果结构恢复性能的标准。我们进行了广泛的模拟研究,以在所提出的标准下研究各种基于树的探索性亚组方法的实证性能。还包括一个实际数据应用,以说明方法评估的必要性和重要性。